Fanconi anemia and DNA repair

被引:127
作者
Grompe, M
D'Andrea, A
机构
[1] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Pediat Oncol, Boston, MA 02115 USA
关键词
D O I
10.1093/hmg/10.20.2253
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fanconi anemia (FA) is an autosomal recessive disorder caused by defects in at least eight distinct genes FANCA, B, C, D1, D2, E, F and G. The clinical phenotype of all FA complementation groups is similar and is characterized by progressive bone marrow failure, cancer proneness and typical birth defects. The principal cellular phenotype is hypersensitivity to DNA damage, particularly interstrand DNA crosslinks. The FA proteins constitute a multiprotein pathway whose precise biochemical function(s) remain unknown. Five of the FA proteins (FANCA, C, E, F and G) interact in a nuclear complex upstream of FANCD2. FANCB and FANCD1 have not yet been cloned, but it is likely that FANCB is part of the nuclear complex and that FANCD1 acts downstream of FANCD2. The FA nuclear complex regulates the mono-ubiquitination of FANCD2 in response to DNA damage, resulting in targeting of this protein into nuclear foci. These foci also contain BRCA1 and other DNA damage response proteins. In male meiosis, FANCD2 also co-localizes with BRCA1 at synaptonemal complexes. Together, these data suggest that the FA pathway functions primarily as a DNA damage response system, although its exact role (direct involvement in DNA repair versus indirect, facilitating role) has not yet been defined.
引用
收藏
页码:2253 / 2259
页数:7
相关论文
共 101 条
  • [1] DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links
    Akkari, YMN
    Bateman, RL
    Reifsteck, CA
    Olson, SB
    Grompe, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (21) : 8283 - 8289
  • [2] FANCONI-ANEMIA AND ITS VARIABILITY
    ALTER, BP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1993, 85 (01) : 9 - 14
  • [3] HEMATOLOGIC ABNORMALITIES IN FANCONI-ANEMIA
    ALTER, BP
    [J]. BLOOD, 1995, 85 (04) : 1148 - 1148
  • [4] ALTER BP, 1994, ARCH PEDIAT ADOL MED, V148, P661
  • [5] Alter BP, 1996, AM J HEMATOL, V53, P99, DOI 10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.0.CO
  • [6] 2-Z
  • [7] AUERBACH AD, 1993, EXP HEMATOL, V21, P731
  • [8] SUSCEPTIBILITY OF FANCONIS ANEMIA FIBROBLASTS TO CHROMOSOME-DAMAGE BY CARCINOGENS
    AUERBACH, AD
    WOLMAN, SR
    [J]. NATURE, 1976, 261 (5560) : 494 - 496
  • [9] G2 CHROMOSOMAL RADIOSENSITIVITY IN FANCONIS ANEMIA
    BIGELOW, SB
    RARY, JM
    BENDER, MA
    [J]. MUTATION RESEARCH, 1979, 63 (01): : 189 - 199
  • [10] MOLECULAR DOSIMETRY FOR SISTER-CHROMATID EXCHANGE INDUCTION AND CYTOTOXICITY BY MONOFUNCTIONAL AND BIFUNCTIONAL ALKYLATING-AGENTS
    BODELL, WJ
    [J]. MUTATION RESEARCH, 1990, 233 (1-2): : 203 - 210